Skip to main content
. 2023 Jan 6;23(1):15–25. doi: 10.17305/bjbms.2022.7953

Figure 1.

Figure 1.

A morphology (Image A; magnification 40×) of poorly differentiated pulmonary non-small cell lung cancer with a marked nuclear atypia with diffuse and strong membranous PD-L1 expression (Image B; SP142 clone, magnification 20×). PD-L1: Programmed cell death ligand 1.